Northern Trust’s Immunome IMNM Stock Holding History
Bought
Maintained
Sold
Other funds holding IMNM
RG
VCM
DCM
ES
Northern Trust's IMNM Position: Q1 2026 in Review
Northern Trust increased its Immunome (IMNM) stake by 8.5% in Q1 2026, buying an estimated $1.57M and bringing the position to 899,146 shares worth $19.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1691.
Northern Trust first reported a position in IMNM in Q4 2020 and has held it in 21 quarters since. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.
- Northern Trust held 899,146 shares of Immunome worth $19.7M as of Q1 2026.
- Northern Trust bought 70,445 Immunome shares in Q1 2026, an estimated $1.57M.
- Immunome made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #1691 holding.
- Northern Trust first reported a position in Immunome in Q4 2020 and has held it in 21 quarters since.
- 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.